Concepedia

Publication | Open Access

Erenumab in chronic migraine

109

Citations

19

References

2019

Year

Abstract

This study provides Class II evidence that for patients with CM, erenumab treatment improves HRQoL, headache impact, and disability.

References

YearCitations

Page 1